Laura Koskenvuo's research into rectal cancer treatment earned her the distinguished 'Best of the 12 Best' award at this year's ESCP conference in Vilnius. In a post-conference interview, she and Nicolas Avellaneda discussed her study, which has the potential to shift current treatment protocols by highlighting the benefits of oral antibiotics in rectal cancer surgeries.
In this short interview, Laura discusses the rigorous process and promising outcomes of her study. As a recognized contribution to the field, the research underscores a commitment to innovation and evidence-based medicine.
